Search filters

List of works by Edgar Faber

A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty ⬇️

scientific article published on November 1, 2010

A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment

scientific article published on 22 June 2015

A significant proportion of patients with chronic myeloid leukemia and suboptimal response according to European Leukemia Net criteria have excellent prognosis without treatment change.

scientific article

ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning

scientific article published on 7 March 2015

Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma: Data from National Czech Registry

scientific article

Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile

scientific article

Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia

scientific article published on 01 December 2011

Comparison of reduced conditionings combining fludarabine with melphalan or 3-day busulfan in patients allografted for myeloid neoplasms

scientific article published on 11 October 2014

Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications

scientific article published on 23 July 2013

Detailed study of imatinib metabolization using high-resolution mass spectrometry

scientific article published on 13 July 2015

Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-α monotherapy

scientific article published on 31 January 2014

Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.

scientific article published on 21 February 2013

First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter

scientific article published on 24 April 2019

Flow injection analysis vs. ultra high performance liquid chromatography coupled with tandem mass spectrometry for determination of imatinib in human plasma.

scientific article published on 13 August 2010

Granulocyte transfusions collected after steroid priming for severe infections during neutropenia: A single center experience

scientific article published on 06 October 2018

Has the time come for induction and maintenance imatinib therapy in chronic myeloid leukemia?

scientific article

High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma

scientific article

High serum carbohydrate antigen-125 (CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score

scientific article published on 26 May 2012

Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.

scientific article

Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher pla

scientific article published in May 2010

Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results.

scientific article published in May 2009

Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting

scientific article published on 11 January 2012

Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial

scientific article published on 17 October 2006

Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.

scientific article

Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells ⬇️

scientific article published on January 12, 2011

Interferon-alpha in chronic myeloid leukemia revisited: a long-term retrospective study in Central and Northern Moravia.

scientific article published on 27 November 2012

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients

scientific article

Intermittent dosage of imatinib mesylate in CML patients with a history of significant hematologic toxicity after standard dosing

scientific article published on 01 June 2006

Isotope dilution direct injection mass spectrometry method for determination of four tyrosine kinase inhibitors in human plasma.

scientific article

Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.

scientific article published in March 2011

Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation

scientific article published on 6 October 2009

Metabolite Profiling of the Plasma and Leukocytes of Chronic Myeloid Leukemia Patients

scientific article published on 28 July 2016

Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis.

scientific article published on 19 April 2017

Operational Cures After Interferon-Alpha in Patients with Chronic Myeloid Leukemia in Central and Northern Moravia ⬇️

scientific article published on December 22, 2011

Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia

scientific article published in May 2010

Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation

scientific article (publication date: June 2009)

Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia

scientific article published on 23 July 2009

Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin

scientific article published on 14 September 2019

Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.

scientific article

Reduced relative dose intensity of primary chemotherapy does not influence prognosis of patients with Hodgkin lymphoma

scientific article published on 10 April 2013

Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission

scientific article published on 01 September 2009

Saliva as a diagnostic medium

scientific article

Salivary neutrophils level as an indicator of bone marrow engraftment

scientific article published on 01 December 2009

Second Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma after a Previous Autograft: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

scientific article

Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT

scientific article published on 11 July 2020

Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era.

scientific article published on 4 February 2014

Sources and pathways of spread of vancomycin-resistant enterococci in hemato-oncological patients

scientific article published on 01 July 2006

Spontaneous splenic rupture in a patient with acute promyelocytic leukaemia during induction chemotherapy.

scientific article

Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.

scientific article

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

scientific article published on 29 June 2020

The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib

scientific article published in February 2024

Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration

scientific article published in January 2003

Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry

scientific article published in August 2011

Ultrafast Online SPE-MS/MS Method for Quantification of 3 Tyrosine Kinase Inhibitors in Human Plasma.

scientific article published in August 2016

[Targeted treatment of chronic myeloid leukemia in the elderly patients]

scientific article published in September 2015

Paulina is supported by:

About Paulina

Help